Management of Tamaka shwasa

Comparative Clinical Study to Evaluate the Effect of Karchura arka (Curcuma zedoaria Rosc.) and Parnayavani arka (Coleus aromaticus Benth.) in Tamaka shwasa vis-a-vis Bronchial Asthma - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/071857

Enrollment

Registered

2024-08-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects having classical symptoms of Tamaka Shwasa with atleast 3 symptoms and for a duration of atleast 3 months are selected for the study Subjects who are willing to be a part of research work and are ready to sign the written consent will be selected Mild to Moderate condition according to GINA parameters Peak Expiratory Flow Rate within 60 to 90 percentage

Exclusion criteria

Exclusion criteria: Peak Expiratory Flow Rate less than 60 percentage History of any Cardiac involvement Cyanosis Uncontrolled Diabetes Mellitus and Hypertension Pregnant and Lactating women Any anatomical defect in airway and other complicated respiratory disorders like TB Emphysema Bronchiectasis Carcinoma etc

Design outcomes

Primary

Measure	Time frame
Assessment of Subjective parameters will be done based on classical symptoms of Tamaka Shwasa Assessment of Objective parameters will be done based on Auscultation Peak Expiratory Flow Rate Timepoint: 15days	—

Secondary

Measure	Time frame
Assessment of Severity will be done Before Treatment After Treatment & during the Follow upTimepoint: 22 days	—

Countries

India

Contacts

Public ContactDr M S Veena

Government Ayurveda Medical College

mullur.vina@gmail.com9591030698

Outcome results